MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma-Reference-Cited by-同舟云学术

MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma

Published:2013-04-02 Issue:7 Volume:19 Page:477-483
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Li Rui-Yan¹,Chen Ling-Chao¹,Zhang Hai-Yan²,Du Wen-Zhong¹,Feng Yan¹,Wang Han-Bing¹,Wen Jin-Qiong¹,Liu Xin¹,Li Xian-Feng¹,Sun Ying¹,Yang Dong-Bo¹,Jiang Tao³,Li Yong-Li¹,Jiang Chuan-Lu¹

Affiliation:

1. Department of Neurosurgery; The Second Affiliated Hospital of Harbin Medical University; Harbin; China

2. Department of Gynecology; Obstetrics and Gynecology Hospital of Fudan University; Shanghai; China

3. Department of Neurosurgery; Tiantan Hospital; Capital Medical University; Beijing; China

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cns.12089/fullpdf

Reference35 articles.

1. A brief review on the mechanisms of miRNA regulation;Cai;Genomics Proteomics Bioinformatics,2009

2. MicroRNA signatures in human cancers;Calin;Nat Rev Cancer,2006

3. miR-137 is frequently down-regulated in glioblastoma is a negative regulator of Cox-2;Chen;Eur J Cancer,2012

4. Targeting miR-21 in glioma: a small RNA with big potential;Moore;Expert Opin Ther Targets,2010

5. Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro;Ren;J Biomater Sci Polym Ed,2010

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial Mechanisms in Temozolomide Resistance: Unraveling the Complex Interplay and Therapeutic Strategies in Glioblastoma;Mitochondrion;2024-03

2. Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer;European Journal of Pharmacology;2023-04

3. A rationally identified panel of microRNAs targets multiple oncogenic pathways to enhance chemotherapeutic effects in glioblastoma models;Scientific Reports;2022-07-14

4. Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma;Neurotherapeutics;2022-03

5. MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52;Journal of Healthcare Engineering;2022-02-16